Psychological adjustment and knowledge about hereditary hemochromatosis in a clinic-based sample: A prospective study

Journal of Genetic Counseling

Volumn 14, Issue 6, 2005, Pages 453-463

  Meiser, Bettina ^a,b   Dunn, Stewart ^c   Dixon, Jeannette ^d   Powell, Lawrie W ^d  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Hereditary hemochromatosis; Knowledge; Psychological adjustment; Screening behaviors

Indexed keywords

ADJUSTMENT; ADULT; ARTICLE; CONFIDENCE INTERVAL; DISTRESS SYNDROME; FEMALE; GENE MUTATION; GENETIC DISORDER; HEALTH PRACTITIONER; HEALTH SURVEY; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; MALE; MENTAL HEALTH; OUTCOMES RESEARCH; OUTPATIENT DEPARTMENT; PATIENT REFERRAL; POPULATION; PROSPECTIVE STUDY; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RECALL; SAMPLE SIZE; SCIENCE; SCORING SYSTEM; SHORT FORM 36; STROKE; VICTIM;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AGED; ATTITUDE TO HEALTH; AWARENESS; FEMALE; FOLLOW-UP STUDIES; GENETIC COUNSELING; GENETIC SCREENING; GENOTYPE; HEALTH SURVEYS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 33644618336     PISSN: 10597700     EISSN: 15733599     Source Type: Journal    
DOI: 10.1007/s10897-005-6192-y     Document Type: Article

References (42)

1. Adams, P. C. (1995). Screening blood donors for hereditary hemochromatosis: Decision analysis model based o a 30-year database. Gastroenterol, 109, 177-188.
2. Adams, P. C., & Speechley, M. (1996). The effect of arthritis on the quality of life in hereditary hemochromatosis. J Rheumatol, 123, 707-710.
3. Allen, K., & Williamson, R. (1999). Should we genetically test everyone for haemochromatosis? J Med Ethics, 25, 209-214.
4. Australian Bureau of Statistics. (1997). National Health Survey: SF-36 Population Norms. ABS Catalogue No. 4399.0: Canberra.
5. Axworthy, D., Brock, D. J. H., Bobroww, M., & Marteau, T. M. (1996). Psychological impact of population-based carrier testing for cystic fibrosis: 3-year follow-up. Lancet, 347, 1443-1446.
6. Bassett, M., Dunn, C., Battese, K., & Peek, K. (2001). Acceptance of neonatal genetic screening for hereditary hemochromatosis by informed parents. Genet Test, 5, 317-320.
7. Bekker, H., Denniss, G., Modell, M., Bobrow, M., & Marteau, T. (1994). The impact of population based screening for carriers of cystic fibrosis. J Med Genet, 31, 364-368.
8. Beutler, E., Felliti, V., Kaziol, J., Ho, N., & Gelbart, T. (2002). Penetrance of 845GA (C282Y) HFE hereditary hemochromatosis mutation in the USA. Lancet, 359, 211-218.
9. Bomford, A. (2002). Genetics of haemochromatosis. Lancet, 360, 1673-1681.
10. Burke, W., Press, N., & McDonnell, S. M. (1998a). Hemochromatosis: Genetics helps to define a multifactorial disease. Clin Genet, 54, 44-52.
11. Burke, W., Thomson, E., Khoury, M. J., McDonnell, S. M., Press, N., Adams, P. C., et al. (1998b). Hereditary hemochromatosis: Gene discovery and its implications for population-based screening. JAMA, 280, 172-178.
12. Cella, D. F., Mahon, S. M., & Donovan, M. I. (1990). Cancer recurrence as a traumatic event. Behav Med, 16, 15-22.
13. Cogswell, M., Burke, W., McDonnell, S., & Franks, A. (1999). Screening for hemochromatosis: A public health perspective. Am J Prev Med.
14. Collins, V., Meiser, B., Halliday, J., Gaff, C., & St John, J. (Submitted to Cancer on 10/7/2004.). Screening and preventive behaviour one year following predictive genetic testing for hereditary non-polyposis colorectal cancer.
15. Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., et al. (1996). A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet, 13, 399-408.
16. Gertig, D., Fletcher, A., & Hopper, J. (2002). Public health aspects of genetic screening for hereditary hemochromatosis in Australia. Austr NZ J Pub Health, 26, 518-524.
17. Hicken, B., Calhoun, D., & Tucker, D. (2003). Genetic testing for haemochromatosis: Attitudes and acceptability among young and older adults. Genet Test, 7, 235-239.
18. Hicken, B. L., Calhoun, D. A., Barton, J. C., & Tucker, D. C. (2004). Attitudes about and psychosocial outcomes of HFE genotyping for hemochromatosis. Genet Test, 8, 90-7.
19. Hornsby, J., Sappington, J., Mongan, P., Gullen, W., Bono, S., & Altekruse, E. (1985). Risk for Bladder Cancer. JAMA, 253, 1899-1902.
20. Jarvinen, H. J., Aarnio, M., Mustonen, H. et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary non-polyposis colorectal cancer. Gastroenterol, 188, 829-834.
21. Jazwinska, E. C., Cullen, L. M., & Busfield, F.E.A. (1996). Haemochromatosis and HLA-H. Nat Genet, 13, 399-408.
22. Kerlikowske, K., Grady, D., Barclay, J., Sickles, E. A., Eaton, A., & Ernster, V. (1996). Effect of age, breast density and family history on the sensitivity of first screening mammography. JAMA, 276, 33-38.
23. Leggett, B. (1996). Iron in an Australian population. J Gastroenterol Hepatol, 11, 1037-1039.
24. Lerman, C., Hughes, C., Croyle, R., Main, D., Durham, C., Snyder, C., et al. (2000). Prophylactic surgery decisions and surveil-lance practices one year following BRCA1/2 testing. Prev Med, 31, 75-80.
25. Lipkus, I. M., & Hollands, J. G. (1999). The visual communication of risk. Journal of the National Cancer Institute Monographs, 25, 149-163.
26. Lobb, E., Butow, P., Meiser, B., Barratt, A., Gaff, C., Young, M.,et al. (2004). Communication and information-giving in high-risk breast cancer consultations: Influence on patient outcomes. British Journal of Cancer 2004;90(2):321-327., 90, 321-327.
27. Lobb, E., Butow, P., Meiser, B., Barratt, A., Tucker, K., Gaff, C., et al. (2002). Tailoring communication in consultations with women from high-risk breast cancer families. Br J Cancer, 87, 502-508.
28. Marteau, T. M., & Bekker, H. (1992). The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol, 31, 301-306.
29. McCaul, K. D., Branstetter, A. D., O'Donnell, S. M., Jacobson, K., & Quinlan, K. B. (1998). A descriptive study of breast cancer worry. J Behav Med, 21, 565-579.
30. McHorney, C. A., Ware, J. E., Lu, C. F. R., & Sherbourne, C. D. (1994). The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care, 32, 40-66.
31. McHorney, C. A., Ware, J. E., & Raczek, A. E. (1993). The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care, 31, 247-263.
32. McLaren, C., Barton, J., Adams, P., Harris, E., Acton, R., Press, N., et al. (2003). Haemochromatosis and Iron Overload Screening (HEIRS) Study design for an evaluation of 100,000 primary care-based adults. Am J Med Sc, 325, 53-62.
33. Meiser, B., Butow, P., Price, M., Bennett, B., Berry, G.,Tucker, K., et al. (2003). Attitudes to prophylactic strategies in Australian women at increased risk for breast cancer. J Women Health, 12, 769-778.
34. Michie, S., French, D., & Marteau, T. (2002). Predictive genetic testing: Mediators and moderators on anxiety. Inter J Behav Med, 9, 309-321.
35. Nisselle, A., Delatyki, M., Collins, V., Metcalfe, S., Aitken, M., du Sart, D., et al. (2004). Implementation of HaemScreen, a workplace-based genetic screening program for haemochromatosis. Clin Genet, 5, 358-367.
36. Olynyk, J., Cullen, D., Aquilia, S., Rossi, E., Summerville, L., & Powell, L. (1999). A population-based study of the clinical expression of the hemochromatosis gene. New Engl J Med, 341, 718-724.
37. Powell, L. (2002). Hereditary hemochromatosis and iron overload diseases. J Gastroenterol Hepatol, 17 (Suppl.), 191-195.
38. Power, T., & Adams, P. (2001). Psychosocial impact of C282Y mutation testing for haemochromatosis. Genet Test, 5, 107-110.
39. Spielberger, C. D. (1983). State-Trait Anxiety Inventory for Adults (Form Y). Mind Garden: Palo Alto.
40. Thewes, B., Meiser, B., & Hickie, I. (2001). Validation of the Impact of Events Scale in women at increased risk of developing hereditary breast cancer. Psycho-Oncol, 10, 459-468.
41. Ware, J., & Kosinski, M. (2001). SF-36 Physical and Mental Health Summary Scales: A manual for users of version 1. Quality Metric Inc.: Lincoln, RI.
42. Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item Short-Form Health Survey (SF-36): I. Conceptual Framework and item selection. Med Care, 30, 473-483.